For hematocrit and reticulocyte counts, recommendations are to repeat these tests daily from the 5th to 7th days of treatment and then frequently until the hematocrit returns to a normal range (11, 14, 15)
Both BPC-157 and TB-500 are on the WADA Prohibited List, Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), prohibited at all times
Research-Grade vs 503A Compounded: Why the Source Determines the Outcome The BPC-157 before and after results that patients read about online come from a wide range of sources with a wide range of quality
Testing often starts with a medical history, examination, complete blood count, and serum total B12 or active B12, depending on local practice
Key Features and Benefits Dual Peptide Synergy: Combines BPC-157 and TB-500 for advanced research applications